Cargando…

2110. Taurolidine-Citrate Lock Solution for the Prevention of Central-Line-associated Bloodstream Infection (CLABSI) in Pediatric Hematology-Oncology and Gastrointestinal Failure Patients with High Baseline CLABSI Rates

BACKGROUND: Catheter- line-associated bloodstream infection (CLABSI) is a serious complication of patients on long-term central venous catheters (CVC). Taurolidine-citrate solution (TCS) is a catheter-lock solution with broad- spectrum antimicrobial action that prevents biofilm formation. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Chia Yin, Ong, Rina Yue Ling, Tan, Natalie Woon Hui, Seah, Valerie Xue Fen, Chan, Mei Yoke, Soh, Shui Yen, Ong, Christina, Lim, Ashley Shi Yuan, Thoon, Koh Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253669/ http://dx.doi.org/10.1093/ofid/ofy210.1766

Ejemplares similares

To Be a CLABSI or Not to Be a CLABSI—That Is the Question: The Epidemiology of Bloodstream Infections in a Large ECMO Population
por: Seidelman, Jessica, et al.
Publicado: (2017)

The Clasp of CLABSI
por: Gopal, Palepu B
Publicado: (2020)

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)
por: Ling, Moi Lin, et al.
Publicado: (2016)

2016. CLABSIs in the Time of COVID
por: Espiritu, Maria Rosa Velasquez, et al.
Publicado: (2022)

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition
por: Hammadi, Ahmed Al, et al.
Publicado: (2018)

Central-line associated bloodstream infection (CLABSI) in patients hospitalized with COVID-19
por: Kang, Minji, et al.
Publicado: (2022)

The evaluation of central-line–associated bloodstream infection (CLABSI) preventability at an academic institution
por: Hsueh, Leon, et al.
Publicado: (2022)

1286 Blood Product Transfusions and the Risk of Central Line-Associated Bloodstream Infections (CLABSI)
por: Hake, Kristin, et al.
Publicado: (2014)

Reducing Central Line Associated Bloodstream Infections (CLABSIs) by Reducing Central Line Days
por: Beville, Amber Shaye McElveen, et al.
Publicado: (2021)

Reducing CLABSI by Increasing Frequency of Incubator Changes
por: Hill, Melissa L., et al.
Publicado: (2022)

Examining CLABSI rates by central-line type
por: DiBiase, Lauren, et al.
Publicado: (2023)

Prevalence of Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care and Medical-Surgical Units
por: Toor, Harjyot, et al.
Publicado: (2022)

95. CAUTI and CLABSI in Hospitalized COVID-19 Patients
por: Knepper, Bryan C, et al.
Publicado: (2020)

Standardization of Care is Key: Reducing CLABSI in Pediatric Patients
por: Thomas, Jennifer D., et al.
Publicado: (2021)

581 Sustained Multidisciplinary CLABSI Bundle in the Burn Center
por: Dao, Sylvia H, et al.
Publicado: (2022)

Controlling the chaos: Information management in home-infusion central-line–associated bloodstream infection (CLABSI) surveillance
por: Hannum, Susan M., et al.
Publicado: (2023)

Reducing Central-Line–Associated Bloodstream Infections (CLABSI): An Improvement Project in a Specialized Tertiary Hospital
por: Mostafa, Fadwa Abu, et al.
Publicado: (2022)

Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line–associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic
por: Ben-Aderet, Michael A., et al.
Publicado: (2023)

Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
por: Olthof, Evelyn D., et al.
Publicado: (2014)

505. Use of CLABSI Prevention Bundle Audits to Decrease CLABSI Rates in COVID Positive ICU Patients in an Acute Care Hospital in New York City During the COVID-19 Epidemic
por: Moss, Marie, et al.
Publicado: (2020)

Four year surveillance of central line-associated bloodstream infection (CLABSI) in neonatal intensive care unit (NICU)
por: Décary, A, et al.
Publicado: (2011)

Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey
por: Valencia, Cristina, et al.
Publicado: (2016)

CLABSI Reduction Strategy: Utilizing Weekly Rounds with an Interdisciplinary Team
por: Welter, Amanda, et al.
Publicado: (2022)

How COVID-19 Impacted CAUTI and CLABSI Rates in Alabama
por: Hyte, Melanie, et al.
Publicado: (2023)

A multifaceted approach in reducing central line associated bloodstream infections (CLABSI) in pediatric icus at a tertiary hospital
por: Balkhy, H, et al.
Publicado: (2015)

777. Implementation of Antimicrobial Impregnated Catheters to Reduce Central Line Associated Bloodstream Infections (CLABSI) in a Pediatric Setting
por: Patel, Ami B, et al.
Publicado: (2021)

Central-line–associated bloodstream infections and central-line–associated non-CLABSI complications among pediatric oncology patients
por: Kelada, Aml S., et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review
por: Satta, Giovanni, et al.
Publicado: (2023)

Blood Culture Result Profile in Patients With Central Line-Associated Bloodstream Infection (CLABSI): A Single-Center Experience
por: Akaishi, Tetsuya, et al.
Publicado: (2023)

WMSS: A Web-Based Multitiered Surveillance System for Predicting CLABSI
por: Noaman, Amin Y., et al.
Publicado: (2018)

Germ Busters: Environmental Cleaning in the Prevention of CLABSIs in Pediatric oncology patients”
por: Gehle, Stephanie C., et al.
Publicado: (2020)

Sustainable neonatal CLABSI surveillance: consensus towards new criteria in the Netherlands
por: Heijting, I. E., et al.
Publicado: (2021)

Sustainable Neonatal CLABSI Surveillance: Consensus Toward New Criteria in the Netherlands
por: Heijting, Ilja, et al.
Publicado: (2021)

2481. Interactive Dashboards for Improved Tracking and Communication of CLABSI Prevention Efforts
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2023)

Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients
por: Reidenberg, Bruce E., et al.
Publicado: (2017)

1668. The SAFER Lines Project: A Mobile-App Strategy for Prevention of Outpatient Central Line Associated Bloodstream Infection (CLABSI)
por: Gohil, Shruti K, et al.
Publicado: (2022)

Surveillance of central line associated bloodstream infection (CLABSI) – comparison of current (CDC/NHSN) and modified criteria: A prospective study
por: Rai, Durgesh, et al.
Publicado: (2023)

Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients
por: Simon, Arne, et al.
Publicado: (2008)

Multiple Drug-Resistant CLABSI from an Extremely Rare Bacterium, Chryseobacterium gleum
por: Anson, David, et al.
Publicado: (2020)

Sustaining Improvements in CLABSI Reduction in a Pediatric Cardiac Intensive Care Unit
por: Gauntt, Jennifer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mvut7gtuf599f92fsuh3g6s8m5